Related Experiment Video
Updated: Feb 7, 2026

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
Published on: September 6, 2024
[Inhalational analgosedation in the intensive care unit : Risk of malignant hyperthermia]
1Anästhesie und Intensivmedizin, SRH Kliniken Landkreis Sigmaringen GmbH, Hohenzollernstraße 40, 72488, Sigmaringen, Deutschland. anaesthesie.sigmaringen@klksig.de.
Background:
According to the 2010 S3 Guidelines, analgosedation is an option for ventilated patients in intensive care units (ICU). Therefore, adverse effects of volatile anesthetics can occur in areas outside of surgical medical fields.
Objective:
The aim is to inform ICU physicians about the clinical and legal challenges of a life-threatening pharmacogenetic reaction to inhalational anesthetics, malignant hyperthermia (MH).
Discussion:
Consequences of an MH crisis for doctors, patients, and relatives regarding patient rights legislation, as well as insurance and employment issues with respect to the German Genetic Diagnostics Act are discussed.
Related Concept Videos
Measurement: Derived Units
Inhaled Medications
Measurement: Standard Units
Pulmonary Ventilation: Inhalation
Boyle's law becomes particularly pertinent when examining respiratory...
Relative Risk
Inhalational Anesthetics: Overview

